enVVeno Medical (NVNO) Accounts Payables (2017 - 2026)

enVVeno Medical's Accounts Payables history runs 10 years deep, the most recent figure standing at $813000.0 for Q1 2026.

• On a quarterly basis, Accounts Payables fell 37.03% year-over-year to $813000.0 in Q1 2026; TTM through Mar 2026 was $813000.0, a 37.03% decrease from a year earlier, with the FY2025 full-year figure at $358000.0, down 64.41% from the prior year.
• Accounts Payables grew to $813000.0 in Q1 2026 per NVNO's latest filing, from $358000.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $2.6 million in Q2 2025 and bottomed at $358000.0 in Q4 2025.
• The 5-year median for Accounts Payables is $1.1 million (2024), against an average of $1.2 million.
• Across the five-year window, Accounts Payables surged 239.32% in 2023 and slumped 64.41% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $1.2 million in 2022, then fell by 15.05% to $1.0 million in 2023, then retreated by 2.61% to $1.0 million in 2024, then slumped by 64.41% to $358000.0 in 2025, then surged by 127.09% to $813000.0 in 2026.
• Per Business Quant, the three latest NVNO Accounts Payables figures stand at $813000.0 (Q1 2026), $358000.0 (Q4 2025), and $2.1 million (Q3 2025).